XML 99 R79.htm IDEA: XBRL DOCUMENT v3.21.2
Business acquisition - Pro forma financial results (Details) - iGenomX International Genomics Corporation (iGenomX) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Business Acquisition [Line Items]    
Revenue $ 132,599 $ 90,650
Net loss attributable to common stockholders $ (153,007) $ (141,054)